Axogen Inc. AXGN
Super Investor & Insider
2
Fondi che lo detengono
#631
Rank consenso
2.9%
% dei portafogli
$12.5M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| First Eagle Investment Management · First Eagle Investment Management | 0.02% | Reduce 13% | 354,590 | $11.7M |
| Mairs & Power · Mairs & Power | 0.01% | — | 22,000 | $728,860 |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Axogen Inc. is a leading developer and marketer of innovative surgical solutions for peripheral nerve regeneration and repair. The company specializes in biologically active technologies, including the Avance Nerve Graft, an off-the-shelf processed human nerve allograft that bridges severed peripheral nerves without re…
SectorHealthcare
ExchangeNASDAQ
IndustryMedical Devices
CountryUnited States
Employees622
TickerAXGN
Statistics
Market Cap$2.36B
Revenue (TTM)$225.2M
Net Income-$15.7M
Net Margin-7.0%
EPS$-0.64
P/E-124.65
P/S9.46
P/B9.20
EV/EBITDA-991.76
ROE-18.0%
Dividend Yield—
Price$44.36
Data: Twelve Data · Revenue = mcap / P/S